Head and Neck Cancer Therapeutics Market Report

Global and Region Head and Neck Cancer Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：160
  • REPORT CODE：GMM1011583
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Head and Neck Cancer Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Head and Neck Cancer Therapeuticsmarket, defines the market attractiveness level of Head and Neck Cancer Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Head and Neck Cancer Therapeutics industry, describes the types of Head and Neck Cancer Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Head and Neck Cancer Therapeutics market and the development prospects and opportunities of Head and Neck Cancer Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Head and Neck Cancer Therapeutics market in Chapter 13.

    By Player:

    • Boston Biomedical, Inc

    • Sanofi SA

    • AbbVie Inc

    • AstraZeneca Plc

    • Astellas Pharma Inc

    • Eli Lilly and Company

    • Bristol-Myers Squibb Company

    • Bayer AG

    • Teva Pharmaceutical Industries Limited

    • AB Science SA

    • Pfizer Inc

    • Merck & Co, Inc

    • Sun Pharmaceutical Industries Ltd

    • F Hoffmann-La Roche Ltd (Genentech, Inc,)

    • Fresenius Medical Care AG & Co KGaA

    By Type:

    • Surgery

    • Radiation Therapy

    • Chemotherapy

    • Immunotherapy

    • Targeted Therapy

    By End-User:

    • Lip and Oral Cavity Cancer

    • Laryngeal Cancer

    • Oropharyngeal Cancer

    • Salivary Gland Cancer

    • Nasopharyngeal Cancer

    • Hypopharyngeal Cancer

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Head and Neck Cancer Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Head and Neck Cancer Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Head and Neck Cancer Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Head and Neck Cancer Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Head and Neck Cancer Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.2 United States Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.3 Europe Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.4 China Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.5 Japan Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.6 India Head and Neck Cancer Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Head and Neck Cancer Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Head and Neck Cancer Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Head and Neck Cancer Therapeutics Consumption Forecast (2022-2028)

    9 Global Head and Neck Cancer Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Head and Neck Cancer Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Surgery Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • 9.2 Global Head and Neck Cancer Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Lip and Oral Cavity Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Laryngeal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Oropharyngeal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Salivary Gland Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Nasopharyngeal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Hypopharyngeal Cancer Consumption and Growth Rate (2017-2022)

    10 Global Head and Neck Cancer Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Surgery Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Lip and Oral Cavity Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Laryngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Oropharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Salivary Gland Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Nasopharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Hypopharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

    11 Global Head and Neck Cancer Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Head and Neck Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Head and Neck Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Head and Neck Cancer Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Head and Neck Cancer Therapeutics Market Competitive Analysis

    • 14.1 Boston Biomedical, Inc

      • 14.1.1 Boston Biomedical, Inc Company Details

      • 14.1.2 Boston Biomedical, Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Boston Biomedical, Inc Head and Neck Cancer Therapeutics Product and Service

    • 14.2 Sanofi SA

      • 14.2.1 Sanofi SA Company Details

      • 14.2.2 Sanofi SA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Sanofi SA Head and Neck Cancer Therapeutics Product and Service

    • 14.3 AbbVie Inc

      • 14.3.1 AbbVie Inc Company Details

      • 14.3.2 AbbVie Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AbbVie Inc Head and Neck Cancer Therapeutics Product and Service

    • 14.4 AstraZeneca Plc

      • 14.4.1 AstraZeneca Plc Company Details

      • 14.4.2 AstraZeneca Plc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AstraZeneca Plc Head and Neck Cancer Therapeutics Product and Service

    • 14.5 Astellas Pharma Inc

      • 14.5.1 Astellas Pharma Inc Company Details

      • 14.5.2 Astellas Pharma Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Astellas Pharma Inc Head and Neck Cancer Therapeutics Product and Service

    • 14.6 Eli Lilly and Company

      • 14.6.1 Eli Lilly and Company Company Details

      • 14.6.2 Eli Lilly and Company Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Eli Lilly and Company Head and Neck Cancer Therapeutics Product and Service

    • 14.7 Bristol-Myers Squibb Company

      • 14.7.1 Bristol-Myers Squibb Company Company Details

      • 14.7.2 Bristol-Myers Squibb Company Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Bristol-Myers Squibb Company Head and Neck Cancer Therapeutics Product and Service

    • 14.8 Bayer AG

      • 14.8.1 Bayer AG Company Details

      • 14.8.2 Bayer AG Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer AG Head and Neck Cancer Therapeutics Product and Service

    • 14.9 Teva Pharmaceutical Industries Limited

      • 14.9.1 Teva Pharmaceutical Industries Limited Company Details

      • 14.9.2 Teva Pharmaceutical Industries Limited Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Teva Pharmaceutical Industries Limited Head and Neck Cancer Therapeutics Product and Service

    • 14.10 AB Science SA

      • 14.10.1 AB Science SA Company Details

      • 14.10.2 AB Science SA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 AB Science SA Head and Neck Cancer Therapeutics Product and Service

    • 14.11 Pfizer Inc

      • 14.11.1 Pfizer Inc Company Details

      • 14.11.2 Pfizer Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pfizer Inc Head and Neck Cancer Therapeutics Product and Service

    • 14.12 Merck & Co, Inc

      • 14.12.1 Merck & Co, Inc Company Details

      • 14.12.2 Merck & Co, Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Merck & Co, Inc Head and Neck Cancer Therapeutics Product and Service

    • 14.13 Sun Pharmaceutical Industries Ltd

      • 14.13.1 Sun Pharmaceutical Industries Ltd Company Details

      • 14.13.2 Sun Pharmaceutical Industries Ltd Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Sun Pharmaceutical Industries Ltd Head and Neck Cancer Therapeutics Product and Service

    • 14.14 F Hoffmann-La Roche Ltd (Genentech, Inc,)

      • 14.14.1 F Hoffmann-La Roche Ltd (Genentech, Inc,) Company Details

      • 14.14.2 F Hoffmann-La Roche Ltd (Genentech, Inc,) Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 F Hoffmann-La Roche Ltd (Genentech, Inc,) Head and Neck Cancer Therapeutics Product and Service

    • 14.15 Fresenius Medical Care AG & Co KGaA

      • 14.15.1 Fresenius Medical Care AG & Co KGaA Company Details

      • 14.15.2 Fresenius Medical Care AG & Co KGaA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Fresenius Medical Care AG & Co KGaA Head and Neck Cancer Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Head and Neck Cancer Therapeutics

    • Figure Head and Neck Cancer Therapeutics Picture

    • Table Global Head and Neck Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Head and Neck Cancer Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Head and Neck Cancer Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Head and Neck Cancer Therapeutics Consumption by Country (2017-2022)

    • Figure United States Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Head and Neck Cancer Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Head and Neck Cancer Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Head and Neck Cancer Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Surgery Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Lip and Oral Cavity Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Laryngeal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Oropharyngeal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Salivary Gland Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Nasopharyngeal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Hypopharyngeal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lip and Oral Cavity Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Laryngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oropharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Salivary Gland Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Nasopharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypopharyngeal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Head and Neck Cancer Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Head and Neck Cancer Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table Boston Biomedical, Inc (Foundation Year, Company Profile and etc.)

    • Table Boston Biomedical, Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boston Biomedical, Inc Head and Neck Cancer Therapeutics Product and Service

    • Table Sanofi SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi SA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Head and Neck Cancer Therapeutics Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Head and Neck Cancer Therapeutics Product and Service

    • Table AstraZeneca Plc (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Plc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Plc Head and Neck Cancer Therapeutics Product and Service

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Head and Neck Cancer Therapeutics Product and Service

    • Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Company Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Company Head and Neck Cancer Therapeutics Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Head and Neck Cancer Therapeutics Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Head and Neck Cancer Therapeutics Product and Service

    • Table Teva Pharmaceutical Industries Limited (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Limited Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Limited Head and Neck Cancer Therapeutics Product and Service

    • Table AB Science SA (Foundation Year, Company Profile and etc.)

    • Table AB Science SA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science SA Head and Neck Cancer Therapeutics Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Head and Neck Cancer Therapeutics Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Head and Neck Cancer Therapeutics Product and Service

    • Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Industries Ltd Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Ltd Head and Neck Cancer Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Genentech, Inc,) (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd (Genentech, Inc,) Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd (Genentech, Inc,) Head and Neck Cancer Therapeutics Product and Service

    • Table Fresenius Medical Care AG & Co KGaA (Foundation Year, Company Profile and etc.)

    • Table Fresenius Medical Care AG & Co KGaA Head and Neck Cancer Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Medical Care AG & Co KGaA Head and Neck Cancer Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US